This event has ended. Visit the official site or create your own event on Sched.
View analytic
Saturday, April 28 • 8:35am - 9:35am
Oculus Virtual Reality View: New Biologics for Improved Skin Clearance in Psoriasis

Sign up or log in to save this to your schedule and see who's attending!

Feedback form is now closed.
Advances in understanding psoriasis pathophysiology have led to a variety of anti-psoriatic therapies, including small molecules and biologic agents. Current and emerging biologic agents may confer improved disease management as well as the potential to reduce associated comorbidities, such as psoriatic arthritis, compared with traditional systemic treatments. Thus, the need to define treatment goals and measure treatment outcomes by means of parameters of clinical severity and quality of life has intensified.

This session will focus on the underlying immunologic interaction and signaling mechanisms in psoriatic diseases as a foundation for the latest targeted treatments, such as mechanisms underlying itch, the role of inflammation in psoriatic and cardiovascular disease, and the mechanisms by which some targeted agents provide more rapid responses and improved patient outcomes. Factors such as quality of life and self-perception that can help clinicians differentiate among available treatment options will be explored. Lastly, key learnings will be applied by integrating individual patient needs, existing comorbidities, patient preferences, and available targeted and biologic agents into individualized treatment plans. 

avatar for Joel M. Gelfand, MD, MSCE

Joel M. Gelfand, MD, MSCE

Professor, Dermatology and Epidemiology; Vice Chair, Clinical Research; Director, Psoriasis and Phototherapy Treatment Center, University of Pennsylvania Perelman School of Medicine
Joel M. Gelfand is Professor of Dermatology and of Epidemiology (tenured); Vice Chair of Clinical Research (Dermatology), Senior Scholar, Center for Clinical Epidemiology and Biostatistics; Associate Fellow, Center for Public Health Initiatives; Medical Director of the Clinical Studies... Read More →

Saturday April 28, 2018 8:35am - 9:35am